CD80 and neoplasm: Consistent with this finding, in NRP-B7-H3 CAR T cell-treated mice, significantly more CAR TSCM cells and CAR TCM cells were detected in peripheral blood of mice with low tumor burden than in mice with high tumor burden (Fig. 6i).